These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 22172433

  • 1. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
    White WB, Grady D, Giudice LC, Berry SM, Zborowski J, Snabes MC.
    Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
    [Abstract] [Full Text] [Related]

  • 2. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM, Simon JA.
    Maturitas; 2009 Jul 20; 63(3):213-9. PubMed ID: 19487090
    [Abstract] [Full Text] [Related]

  • 3. Testosterone for low libido in postmenopausal women not taking estrogen.
    Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarege A, Studd J, APHRODITE Study Team.
    N Engl J Med; 2008 Nov 06; 359(19):2005-17. PubMed ID: 18987368
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Davis SR, Braunstein GD.
    J Sex Med; 2012 Apr 06; 9(4):1134-48. PubMed ID: 22304681
    [Abstract] [Full Text] [Related]

  • 7. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR.
    Fertil Steril; 2008 Jul 06; 90(1):129-40. PubMed ID: 18023435
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW.
    Menopause; 2006 Jul 06; 13(3):387-96. PubMed ID: 16735935
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L.
    J Sex Med; 2007 Jul 06; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [Abstract] [Full Text] [Related]

  • 10. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg SA, Simon JA, Goldstein I.
    J Sex Med; 2008 Sep 02; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O'Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R.
    Menopause; 2006 Sep 02; 13(5):770-9. PubMed ID: 16932240
    [Abstract] [Full Text] [Related]

  • 13. EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome.
    White WB, Bakris GL, Bergenstal RM, Cannon CP, Cushman WC, Fleck P, Heller S, Mehta C, Nissen SE, Perez A, Wilson C, Zannad F.
    Am Heart J; 2011 Oct 02; 162(4):620-626.e1. PubMed ID: 21982652
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ, Brown L, Yuan J, Kissling R, Kingsberg SA.
    J Sex Med; 2017 Jun 02; 14(6):834-842. PubMed ID: 28583342
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
    El-Hage G, Eden JA, Manga RZ.
    Climacteric; 2007 Aug 02; 10(4):335-43. PubMed ID: 17653960
    [Abstract] [Full Text] [Related]

  • 20. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.
    Panay N, Al-Azzawi F, Bouchard C, Davis SR, Eden J, Lodhi I, Rees M, Rodenberg CA, Rymer J, Schwenkhagen A, Sturdee DW.
    Climacteric; 2010 Apr 02; 13(2):121-31. PubMed ID: 20166859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.